Top

19-10-2015 | Ophthalmologic cancers | Article

A case–control study of sporadic retinoblastoma in relation to maternal health conditions and reproductive factors: a report from the Children’s Oncology group

Journal: BMC Cancer

Authors: Julia E. Heck, Negar Omidakhsh, Saeedeh Azary, Beate Ritz, Ondine S. von Ehrenstein, Greta R. Bunin, Arupa Ganguly

Publisher: BioMed Central

Abstract

Background

The early age at retinoblastoma occurrence, the most common eye malignancy in childhood, suggests that perinatal factors may contribute to its etiology.

Methods

In a large multicenter study of non-familial retinoblastoma, we conducted structured interviews with the parents of 280 cases and 146 controls to elicit information on health during the perinatal period. We used unconditional logistic regression to assess associations between retinoblastoma and parental fertility treatment, birth control use in the year prior to pregnancy, maternal health conditions and the use of prescription medications during pregnancy, and whether mothers breastfed the index child.

Results

Bilateral retinoblastoma was related to maternal underweight (body mass index <18.5) prior to pregnancy [Odds Ratio (OR) = 4.5, 95 % confidence interval (CI) 1.0, 20]. With regards to unilateral retinoblastoma, we observed a negative association with the use of condoms in the year prior to pregnancy (OR = 0.4, CI 0.2, 0.9), and a trend towards a positive association with maternal diabetes (OR = 2.2, CI 0.8, 6.6).

Conclusions

Results from our study suggest a role for several maternal health and reproductive factors. Given that there are few epidemiologic studies of retinoblastoma, our results require replication in studies which utilize medical record review.

Broaddus E, Topham A, Singh AD. Incidence of retinoblastoma in the USA: 1975–2004. Br J Ophthalmol. 2009;93(1):21–3.CrossRefPubMed

Leiderman YI, Kiss S, Mukai S. Molecular genetics of RB1--the retinoblastoma gene. Semin Ophthalmol. 2007;22(4):247–54.CrossRefPubMed

Kato MV, Ishizaki K, Shimizu T, Ejima Y, Tanooka H, Takayama J, et al. Parental origin of germ-line and somatic mutations in the retinoblastoma gene. Hum Genet. 1994;94(1):31–8.CrossRefPubMed

Hargreave M, Jensen A, Toender A, Andersen KK, Kjaer SK. Fertility treatment and childhood cancer risk: a systematic meta-analysis. Fertil Steril. 2013;100(1):150–61.CrossRefPubMed

Williams CL, Bunch KJ, Stiller CA, Murphy MF, Botting BJ, Wallace WH, et al. Cancer risk among children born after assisted conception. New Engl J Med. 2013;369(19):1819–27.CrossRefPubMed

Heck JE, Lombardi CA, Meyers TJ, Cockburn M, Wilhelm M, Ritz B. Perinatal characteristics and retinoblastoma. Cancer Causes Control. 2012;23(9):1567–75.CrossRefPubMedPubMedCentral

Bunin GR, Meadows AT, Emanuel BS, Buckley JD, Woods WG, Hammond GD. Pre- and postconception factors associated with sporadic heritable and nonheritable retinoblastoma. Cancer Res. 1989;49(20):5730–5.PubMed

Anand B, Ramesh C, Appaji L, Kumari BS, Shenoy AM, Nanjundappa, et al. Prevalence of high-risk human papillomavirus genotypes in retinoblastoma. Br J Ophthal. 2011;95(7):1014–8.CrossRef

Shetty OA, Naresh KN, Banavali SD, Shet T, Joshi R, Qureshi S, et al. Evidence for the presence of high risk human papillomavirus in retinoblastoma tissue from nonfamilial retinoblastoma in developing countries. Pediatr Blood Cancer. 2012;58(2):185–90.CrossRefPubMed

10.

Montoya-Fuentes H, de la Paz R-MM, Villar-Calvo V, Suarez-Rincon AE, Ornelas-Aguirre JM, Vazquez-Camacho G, et al. Identification of DNA sequences and viral proteins of 6 human papillomavirus types in retinoblastoma tissue. Anticancer Res. 2003;23(3C):2853–62.PubMed

11.

Palazzi MA, Yunes JA, Cardinalli IA, Stangenhaus GP, Brandalise SR, Ferreira SA, et al. Detection of oncogenic human papillomavirus in sporadic retinoblastoma. Acta Ophthalmol Scand. 2003;81(4):396–8.CrossRefPubMed

12.

Orjuela M, Castaneda VP, Ridaura C, Lecona E, Leal C, Abramson DH, et al. Presence of human papilloma virus in tumor tissue from children with retinoblastoma: an alternative mechanism for tumor development. Clin Cancer Res. 2000;6(10):4010–6.PubMed

13.

Bhuvaneswari A, Pallavi VR, Jayshree RS, Kumar RV. Maternal transmission of human papillomavirus in retinoblastoma: A possible route of transfer. Indian J Med Paediatr Oncol. 2012;33(4):210–5.CrossRefPubMedPubMedCentral

14.

Ryoo NK, Kim JE, Choung HK, Kim N, Lee MJ, Khwarg SI. Human papilloma virus in retinoblastoma tissues from Korean patients. Korean J Ophthalmol. 2013;27(5):368–71.CrossRefPubMedPubMedCentral

15.

Gillison ML, Chen R, Goshu E, Rushlow D, Chen N, Banister C, et al. Human retinoblastoma is not caused by known pRb-inactivating human DNA tumor viruses. Int J Cancer. 2007;120(7):1482–90.CrossRefPubMed

16.

Hardell L, Dreifaldt AC. Breast-feeding duration and the risk of malignant diseases in childhood in Sweden. Eur J Clin Nutr. 2001;55(3):179–85.CrossRefPubMed

17.

Herbst AL, Ulfelder H, Poskanzer DC. Adenocarcinoma of the vagina. Association of maternal stilbestrol therapy with tumor appearance in young women. New Engl J Med. 1971;284(15):878–81.CrossRefPubMed

18.

Cardy AH, Little J, McKean-Cowdin R, Lijinsky W, Choi NW, Cordier S, et al. Maternal medication use and the risk of brain tumors in the offspring: the SEARCH international case–control study. Int J Cancer. 2006;118(5):1302–8.CrossRefPubMed

19.

Kwan ML, Metayer C, Crouse V, Buffler PA. Maternal illness and drug/medication use during the period surrounding pregnancy and risk of childhood leukemia among offspring. Am J Epidemiol. 2007;165(1):27–35.CrossRefPubMed

20.

Ross JA, Xie Y, Davies SM, Shu XO, Pendergrass TW, Robison LL. Prescription medication use during pregnancy and risk of infant leukemia (United States). Cancer Causes Control. 2003;14(5):447–51.CrossRefPubMed

21.

Orjuela MA, Titievsky L, Liu X, Ramirez-Ortiz M, Ponce-Castaneda V, Lecona E, et al. Fruit and vegetable intake during pregnancy and risk for development of sporadic retinoblastoma. Cancer Epidemiol Biomarkers Prev. 2005;14(6):1433–40.CrossRefPubMed

22.

Lombardi C, Ganguly A, Bunin GR, Azary S, Alfonso V, Ritz B, et al. Maternal diet during pregnancy and unilateral retinoblastoma. Cancer Causes Control. 2015;26(3):387–97.CrossRefPubMed

23.

Rasmussen KM, Yaktine AL. Weight gain during pregnancy: reexamining the guidelines. National Academies Press; Washington DC 2009. http://www.ncbi.nlm.nih.gov/books/NBK32813/

24.

Cnattingius S, Bergstrom R, Lipworth L, Kramer MS. Prepregnancy weight and the risk of adverse pregnancy outcomes. New Engl J Med. 1998;338(3):147–52.CrossRefPubMed

25.

McLaughlin CC, Baptiste MS, Schymura MJ, Nasca PC, Zdeb MS. Maternal and infant birth characteristics and hepatoblastoma. Am J Epidemiol. 2006;163(9):818–28.CrossRefPubMed

26.

Palmer AC. Nutritionally mediated programming of the developing immune system. Advances Nutr. 2011;2(5):377–95.CrossRef

27.

Gopinath B, Baur LA, Wang JJ, Teber E, Liew G, Cheung N, et al. Smaller birth size is associated with narrower retinal arterioles in early adolescence. Microcirculation. 2010;17(8):660–8.CrossRefPubMed

28.

Hellstrom BE. Experimental approach to the pathogenesis of retrolental fibroplasia. V. The influence of the state of nutrition on oxygen-induced changes in the mouse eye. Acta Paediatr. 1956;45(1):43–57.CrossRefPubMed

29.

Orjuela MA, Cabrera-Munoz L, Paul L, Ramirez-Ortiz MA, Liu X, Chen J, et al. Risk of retinoblastoma is associated with a maternal polymorphism in dihydrofolatereductase (DHFR) and prenatal folic acid intake. Cancer. 2012;118(23):5912–9.CrossRefPubMedPubMedCentral

30.

Winer RL, Hughes JP, Feng Q, O’Reilly S, Kiviat NB, Holmes KK, et al. Condom use and the risk of genital human papillomavirus infection in young women. New Engl J Med. 2006;354(25):2645–54.CrossRefPubMed

31.

Hogewoning CJ, Bleeker MC, van den Brule AJ, Voorhorst FJ, Snijders PJ, Berkhof J, et al. Condom use promotes regression of cervical intraepithelial neoplasia and clearance of human papillomavirus: a randomized clinical trial. Int J Cancer. 2003;107(5):811–6.CrossRefPubMed

32.

Park H, Lee SW, Lee IH, Ryu HM, Cho AR, Kang YS, et al. Rate of vertical transmission of human papillomavirus from mothers to infants: relationship between infection rate and mode of delivery. Virology J. 2012;9:80.CrossRef

33.

Jones EE, Wells SI. Cervical cancer and human papillomaviruses: inactivation of retinoblastoma and other tumor suppressor pathways. Curr Mol Med. 2006;6(7):795–808.PubMed

34.

Centers for Disease Control and Prevention, American Society for Reproductive Medicine, Society for Assisted Reproductive Technology. 2011 Assisted reproductive technology fertility clinic success rates report. Atlanta: US Department of Health and Human Services; 2013.

35.

Heck JE, Lombardi CA, Cockburn M, Meyers TJ, Wilhelm M, Ritz B. Epidemiology of Rhabdoid Tumors of Early Childhood. Pediatr Blood Cancer. 2013;60(1):77–81.CrossRefPubMed

36.

Heck JE, Meyers TJ, Lombardi C, Park AS, Cockburn M, Reynolds P, et al. Case–control study of birth characteristics and the risk of hepatoblastoma. Cancer Epidemiol. 2013;37(4):390–5.CrossRefPubMedPubMedCentral

37.

Shrestha A, Ritz B, Ognjanovic S, Lombardi CA, Wilhelm M, Heck JE. Early life factors and risk of childhood rhabdomyosarcoma. Frontiers in Public Health. 2013;1:17.CrossRefPubMedPubMedCentral

38.

Kallen B, Finnstrom O, Lindam A, Nilsson E, Nygren KG, Olausson PO. Cancer risk in children and young adults conceived by in vitro fertilization. Pediatrics. 2010;126(2):270–6.CrossRefPubMed

39.

Neelanjana M, Sabaratnam A. Malignant conditions in children born after assisted reproductive technology. Obstet Gynecol Surv. 2008;63(10):669–76.CrossRefPubMed

40.

LaKind JS, Amina Wilkins A, Berlin Jr CM. Environmental chemicals in human milk: a review of levels, infant exposures and health, and guidance for future research. Toxicol Appl Pharmacol. 2004;198(2):184–208.CrossRefPubMed

41.

Werler MM, Mitchell AA, Hernandez-Diaz S, Honein MA. Use of over-the-counter medications during pregnancy. Am J Obstet Gynecol. 2005;193(3 Pt 1):771–7.CrossRefPubMed

42.

Rebordosa C, Kogevinas M, Bech BH, Sorensen HT, Olsen J. Use of acetaminophen during pregnancy and risk of adverse pregnancy outcomes. Int J Epidemiol. 2009;38(3):706–14.CrossRefPubMed

43.

Scialli AR, Ang R, Breitmeyer J, Royal MA. Childhood asthma and use during pregnancy of acetaminophen. A critical review. Reprod Toxicol. 2010;30(4):508–19.CrossRefPubMed

44.

Liew Z, Ritz B, Rebordosa C, Lee PC, Olsen J. Acetaminophen Use During Pregnancy, Behavioral Problems, and Hyperkinetic Disorders. JAMA Pediatr. 2014;168(4):313–20.CrossRefPubMed

45.

Githens PB, Glass CA, Sloan FA, Entman SS. Maternal recall and medical records: an examination of events during pregnancy, childbirth, and early infancy. Birth. 1993;20(3):136–41.CrossRefPubMed

46.

Olson JE, Shu XO, Ross JA, Pendergrass T, Robison LL. Medical record validation of maternally reported birth characteristics and pregnancy-related events: a report from the Children’s Cancer Group. Am J Epidemiol. 1997;145(1):58–67.CrossRefPubMed

47.

Feldman Y, Koren G, Mattice K, Shear H, Pellegrini E, MacLeod SM. Determinants of recall and recall bias in studying drug and chemical exposure in pregnancy. Teratology. 1989;40(1):37–45.CrossRefPubMed

48.

Rockenbauer M, Olsen J, Czeizel AE, Pedersen L, Sorensen HT. Recall bias in a case–control surveillance system on the use of medicine during pregnancy. Epidemiology. 2001;12(4):461–6.CrossRefPubMed

49.

Roberts CL, Bell JC, Ford JB, Hadfield RM, Algert CS, Morris JM. The accuracy of reporting of the hypertensive disorders of pregnancy in population health data. Hypertension in Pregnancy. 2008;27(3):285–97.CrossRefPubMedPubMedCentral

50.

Lydon-Rochelle MT, Holt VL, Cardenas V, Nelson JC, Easterling TR, Gardella C, et al. The reporting of pre-existing maternal medical conditions and complications of pregnancy on birth certificates and in hospital discharge data. Am J Obstet Gynecol. 2005;193(1):125–34.CrossRefPubMed

51.

Lawrence JM, Contreras R, Chen W, Sacks DA. Trends in the prevalence of preexisting diabetes and gestational diabetes mellitus among a racially/ethnically diverse population of pregnant women, 1999–2005. Diabetes Care. 2008;31(5):899–904.CrossRefPubMed

52.

Kwon HL, Belanger K, Bracken MB. Asthma prevalence among pregnant and childbearing-aged women in the United States: estimates from national health surveys. Ann Epidemiol. 2003;13(5):317–24.CrossRefPubMed

53.

Casey BM, Dashe JS, Wells CE, McIntire DD, Byrd W, Leveno KJ, et al. Subclinical hypothyroidism and pregnancy outcomes. Obstet Gynecol. 2005;105(2):239–45.CrossRefPubMed

54.

Le Strat Y, Dubertret C, Le Foll B. Prevalence and correlates of major depressive episode in pregnant and postpartum women in the United States. J Affect Disord. 2011;135(1–3):128–38.CrossRefPubMed

55.

Melville JL, Gavin A, Guo Y, Fan MY, Katon WJ. Depressive disorders during pregnancy: prevalence and risk factors in a large urban sample. Obstet Gynecol. 2010;116(5):1064–70.CrossRefPubMedPubMedCentral